Entering text into the input field will update the search result below

Anthem to cover Veracyte's thyroid cancer test; shares up 2%

May 18, 2017 1:32 PM ETVeracyte, Inc. (VCYT) StockBy: Douglas W. House, SA News Editor
  • Anthem has decided to cover Veracyte's (NASDAQ:VCYT +2%) Afirma Gene Expression Classifier for use in the diagnosis of thyroid cancer for its 40M members. The test identifies patients with benign thyroid nodules whose biopsy results are indeterminate, thereby enabling them to avoid diagnostic surgery.

Recommended For You

More Trending News

About VCYT Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
VCYT--
Veracyte, Inc.